CPC A61K 35/76 (2013.01) [A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 2035/115 (2013.01)] | 20 Claims |
1. A composition, comprising:
a pharmaceutically-acceptable carrier; and
greater than or equal to 1×104 PFU of each of a plurality of bacteriophages, the plurality of bacteriophages comprising:
a first bacteriophage having a genome with greater than or equal to 80% sequence identity to a first one of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, or SEQ ID NO:6;
a second bacteriophage having a genome with greater than or equal to 80% sequence identity to a second one of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, or SEQ ID NO:6;
a third bacteriophage having a genome with greater than or equal to 80% sequence identity to a first one of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:10, or SEQ ID NO:14;
a fourth bacteriophage having a genome with greater than or equal to 80% sequence identity to a second one of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:10, or SEQ ID NO:14;
a fifth bacteriophage having a genome with greater than or equal to 80% sequence identity to a first one of SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9;
a sixth bacteriophage having a genome with greater than or equal to 80% sequence identity to a second one of SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9;
a seventh bacteriophage having a genome with greater than or equal to 80% sequence identity to a first one of SEQ ID NO:12, nucleic acid bases 1-59,985 of SEQ ID NO:13, or SEQ ID NO:15; and
an eighth bacteriophage having a genome with greater than or equal to 80% sequence identity to a second one of SEQ ID NO:12, nucleic acid bases 1-59,985 of SEQ ID NO:13, or SEQ ID NO:15.
|